Pediatric Anaphylaxis: Clinical Features and Identified Risk Factors for Severe Reactions from a Single-Center Study
-
By
-
Wenyu Wang
-
Yueyun Shang
-
Hui Zhang
-
Shuang Ba
-
Tongqiang Zhang
-
April 21, 2026
-
Clinical Scorecard: Pediatric Anaphylaxis: Clinical Features and Identified Risk Factors for Severe Reactions from a Single-Center Study
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | Children aged 1 month to 15 years, as per study findings. |
| Care Setting | |
Key Highlights
- Clarify the significance of drug allergies as a risk factor across age groups.
Guideline-Based Recommendations
Diagnosis
- Use WAO guidelines for diagnosing anaphylaxis based on symptom criteria, including specific criteria.
Management
- Immediate administration of epinephrine for severe reactions, as per WAO guidelines.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Include specific treatment protocols used in the study.
Clinical Best Practices
- Include follow-up care recommendations for children post-anaphylaxis.
References
